Angiomyofibroblastoma of the uterine cervix in a patient with triple negative breast cancer: a case report

Year 2021, Volume: 3 Issue: 2, 181 - 184, 24.04.2021

Dilara Özyiğit Büyüktalancı , Seyran Yiğit , Sultan Deniz Altındağ , Hüseyin Aydoğmuş , Servet Gençdal

https://doi.org/10.38053/acmj.846942

Cited By: 1

Abstract

Angiomyofibroblastoma is an uncommon, benign mesenchymal tumor which generally occurs in the vulvovaginal region. Uterine cervix localisation is uncommon. A 40-year-old female patient, who had been operated becasue of breast carcinoma, presented vaginal bleeding. Examination revealed a polypoid mass located in both vagina and cervix. She underwent total abdominal hysterectomy and bilateral salpingectomy. With the help of typical histopathology and immunohistochemical findings, a diagnosis of “angiomyofibroblastoma” was made. Angiomyofibroblastoma is a benign mesenchymal tumor of unknown pathogenesis. A recognition of this entity is important to avoid misdagnosis of other angiomyxoid neoplasms such as aggressive angiomyxoma.

Keywords

angiomyofibroblastoma, cervix uteri, breast carcinoma

References

• Lee CL, Ng BK, Nurismah MI, Chew KT, Aruku N, Lim P. Concurrent utero-vaginal prolapse with cervical angiomyofibroblastoma : a rare disease with distinct entity. J Surg Acad 2015; 5: 58–61.
• Min JK, Ji NK, Lindsay Ji HS, Chang Lim Hyun SSS, Chul Min Park SYK. Angiomyofibroblastoma of the uterine cervix in a breast cancer patient: A case report. Korean J Obstet 2011; 54: 330.
• Fletcher CD, Tsang WY, Fisher C, Lee KC CJ. Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 1992; 16: 373–82.
• Babala P, Bíró C, Klačko M, Mikloš P, Ondruš D. Angiomyofibroblastoma of the cervix uteri: a case report. Klin Onkol 2011; 24: 133–6.
• Wong YP, Tan GC, Ng PF. Cervical angiomyofibroblastoma: a case report and review of literature. J Obstet Gynaecol (Lahore) 2017; 37: 681–2.
• Roncati L, Pusiol T, Piscioli F, Barbolini G MA. Undetermined cervical smear due to angiomyofibroblastoma of the cervix uteri. J Obstet Gynaecol (Lahore) 2017; 37: 829–30.
• M Varras, C Akrivis, A Demou, E Kitsiou N Antoniou. Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen : clinicopathologic analysis of a case and review of the literature. Int J Gynecol Cancer 2006; 581–5.
• Weis SW GJ. Enzinger and Weiss’s Soft Tissue Tumors. 4th ed. St. Louis: Mosby. In: Enzinger and Weiss’s Soft Tissue Tumors 4th ed St Louis: Mosby 2001. p. 695–723.
• Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 1983; 7: 463–75.
• Salman MC, Kuzey GM, Dogan NU, Yuce K. Aggressive angiomyxoma of vulva recurring 8 years after initial diagnosis. Arch Gynecol Obstet 2009; 280: 485-7.
• Laskin WB, Fetsch JF, Tavassoli FA. Myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract. Hum Pathol 2001; 32: 715–25.
• Salman MC, Ureyen I, Tanas O, Baydar DE, Yuce K. Possible Relationship Between Tamoxifen Therapy and Vaginal Angiomyofibroblastoma. UHOD 1992; 49–52.
• Lee H, Jang KY, Park HS, et al. Angiomyofibroblastoma of the vagina in a breast cancer patient. Pathology 2008; 40: 534–6.
• Kumasaka T, Mitani K, Shiotsu H, Kato H, Joho M, Suda K. Vascular endothelial growth factor expressed by mast cells rather than tumour cells in angiomyofibroblastoma of the vaginal wall. Histopathology 2007; 51: 557–9.
• Saleh MM, Yassin AH, Zaklama M. Recurrent angiomyofibroblastoma of the vagina: a case report. Eur J Gynaecol Oncol 2007; 28: 324.